Results: MHE Question of the Week About Medicare Cap Extension

The results are in and 75% of our readers think the Medicare $2,000 per-year cap on out-of-pocket costs for prescription drugs should not be extended to commercial insurance.

A $3,250 cap went into effect this year and will be lowered to $2,000 next year. At this time, it only applies to Medicare enrollees with Part D coverage.

We want to know what you’re thinking! Every Monday morning, the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We collect your answer and post the results on Friday.